iShares Biotechnology ETF $IBB Shares Purchased by Washington Growth Strategies LLC

Washington Growth Strategies LLC increased its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 4,996.9% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,524 shares of the financial services provider’s stock after purchasing an additional 6,396 shares during the period. iShares Biotechnology ETF accounts for approximately 0.6% of Washington Growth Strategies LLC’s portfolio, making the stock its 27th largest position. Washington Growth Strategies LLC’s holdings in iShares Biotechnology ETF were worth $825,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of IBB. Ramirez Asset Management Inc. acquired a new position in shares of iShares Biotechnology ETF during the first quarter worth $26,000. Financial Gravity Asset Management Inc. acquired a new position in shares of iShares Biotechnology ETF during the first quarter worth $30,000. Woodside Wealth Management LLC acquired a new position in shares of iShares Biotechnology ETF during the first quarter worth $31,000. CX Institutional acquired a new position in shares of iShares Biotechnology ETF during the first quarter worth $32,000. Finally, Garde Capital Inc. acquired a new position in shares of iShares Biotechnology ETF during the first quarter worth $36,000. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

NASDAQ IBB opened at $151.00 on Friday. iShares Biotechnology ETF has a 1 year low of $107.43 and a 1 year high of $151.62. The company has a fifty day moving average of $139.19 and a two-hundred day moving average of $130.00.

iShares Biotechnology ETF Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, September 19th. Shareholders of record on Tuesday, September 16th were paid a $0.0828 dividend. This represents a $0.33 annualized dividend and a yield of 0.2%. The ex-dividend date was Tuesday, September 16th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.